Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation

Transplantation

Volumn 66, Issue 7, 1998, Pages 877-882

  Ratnamohan, V Mala ^b   Chapman, Jeremy ^b   Howse, Helen ^b   Bovington, Karen ^b   Robertson, Paul ^b   Byth, Karen ^b   Allen, Richard ^b   Cunningham, Anthony L ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISOLONE; THYMOCYTE ANTIBODY; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEVER; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; NEUTROPENIA; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS SHEDDING;

ACYCLOVIR; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FORECASTING; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SEROLOGIC TESTS; VIRUS SHEDDING;

EID: 0032532759     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199810150-00011     Document Type: Article

References (41)

1. Boland GJ, Hene RJ, Ververs C, de Hann MA, de Gast GC. Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation. Clin Exp Immunol 1993; 94: 306.
2. Grundy JE, Lui SF, Super M, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988; 2: 132.
3. Chou S. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. J Infect Dis 1989; 160: 11.
4. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992; 53: 68.
5. Chou S, Norman DJ. Effect of OKT3 antibody therapy on cytomegalovirus reactivation in renal transplant recipients. Transplant Proc 1985; 17: 2755.
6. Winston DJ. Prevention of cytomegalovirus disease in transplant recipients. Lancet 1995; 346: 1380.
7. Portela D, Patel R, Larson-Keller JJ, et al. OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. J Infect Dis 1995; 171: 1014.
8. Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet 1994; 343: 577.
9. Fairfax MR, Schacker T, Cone RW, Collier AC, Corey L. Human herpesvirus 6 DNA in blood cells of HIV infected men: correlation of high levels with high CD4 cell counts. J Infect Dis 1995; 169: 1342.
10. Levy JA, Greenspan D, Ferro F, Lennette ET. Frequent isolation of HHV6 from saliva and high seroprevalence of the virus in the population. Lancet 1990; 335: 1047.
11. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human herpesvirus 6 as causal agent for exanthem subitum. Lancet 1988; 1: 1065.
12. Brown NA, Sumaya CV, Liu CR, et al. Fall in human herpesvirus 6 seropositivity with age. Lancet 1988; 2: 396.
13. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N. Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci USA 1991; 88: 5922.
14. Drobyski WR, Eberle M, Majewski D, Baxter-Lowe LA. Prevalence of human herpesvirus 6 variant A and B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J Clin Microbiol 1993; 31: 1515.
15. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Johnson RWG. Human herpesvirus 6 infection in renal transplant recipients. N Engl J Med 1989; 320: 1560.
16. Hoshino K, Nishi T, Adachi H, et al. Human herpesvirus 6 infection in renal allografts: retrospective immunohistochemical study in Japanese recipients. Transpl Int 1995; 8: 169.
17. Ward KN, Gray JJ, Efstathiou S. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989; 28: 69.
18. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 in liver transplant recipients. Transplantation 1997; 64: 674.
19. Cone RW, Hackman RC, Huang MW, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis. N Engl J Med 1993; 329: 156.
20. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Fatal encephalitis due to variant B human herpesvirus 6 infection in a bone marrow transplant recipient. N Engl J Med 1994; 330: 1356.
21. Irving WL, Ratnamohan VM, Hueston LC, Cunningham AL. Dual antibody rises to cytomegalovirus and human herpesvirus type 6: frequency of occurrence in CMV infections and evidence for genuine reactivity to both viruses. J Infect Dis 1990; 27: 910.
22. Knox KK, Carrigan DR. HHV-6 and CMV pneumonitis in immunocompromised patients. Lancet 1994; 343: 1647.
23. Osman HKE, Peiris JSM, Taylor CE, Warwicker P, Jarrett RF, Madeley GR. Cytomegalovirus disease in renal allograft recipients: is human herpesvirus 7 a cofactor for disease progression? J Med Virol 1996; 48: 295.
24. Chan PKS, Peiris JSM, Yuen KY, et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 1997; 53: 295.
25. Buller RS, Bailey TC, Ettinger NA, et al. Use of modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. J Clin Microbiol 1992; 30: 2620.
26. Brytting M, Xu W, Wahren B, Sundqvist V. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Micro 1992; 30: 1937.
27. Wolf DG, Spector SA. Early diagnosis of human cytomegalovirus disease in transplant recipients by DNA amplification in plasma. Transplantation 1993; 56: 330.
28. Fox JC, Kidd M, Griffiths PD, Sweny P, Emery VC. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol 1995; 76: 309.
29. Rasmussen L, Morris S, Zipeto D, et al. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995; 171: 177.
30. Imbert-Marcille B-M, Cantarovich D, Ferre-Aubineau V, Richet B, Soulillou J-P, Billandel S. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas renal transplant recipients. Transplantation 1997; 63: 1476.
31. Stephan F, Fajac A, Grenet D, et al. Prediction value of cytomegalovirus DNA detection by polymerase chain reaction in blood and bronchoalveolar lavage in lung transplant recipients. Transplantation 1997; 63: 1430.
32. Secchiero P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995; 171: 273.
33. Gopal MR, Thomson BJ, Fox J, Tedder RS, Honess RW. Detection by PCR of HHV6 and EBV DNA in blood and oropharynx of healthy adults and HIV seropositive patients. Lancet 1990; 335: 1598.
34. Lawrence GL, Chee M, Craxton MA, Compels UA, Honess RW, Barrell BG. Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol 1990; 64: 287.
35. Demmler GJ, Buffone GJ, Schimbor CM, May R. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988; 158: 1177.
36. Ratnamohan VM, Mathijs JM, McKenzie A, Cunningham AL. HCMV-DNA is detected more frequently than infectious virus in blood leukocytes of immunocompromised patients: a direct comparison of culture-immunofluorescence and PCR for detection of HCMV in clinical specimens. J Med Virol 1992; 38: 252.
37. Irving WL, Cunningham AL. Serological diagnosis of infection with human herpes virus type 6. Br Med J 1990; 300: 156.
38. Jacobs U, Ferber J, Klehr HU. Severe allograft dysfunction after OKT3-induced human herpes virus-6 reactivation. Transplant Proc 1994; 26: 3121.
39. Qavi HB, Green MT, Pearson G, Ablashi D. Possible role of HHV-6 in the development of AIDS retinitis. In Vivo 1994; 8: 527.
40. Mitchell SM, Fox JD, Tedder RS, Gazzard BG, Lightman S. Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol 1994; 43: 336.
41. Akesson-Johansson A, Harmenberg J, Wahren B, Linde A. Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds. Antimicrob Agents Chemother 1990; 34: 2417.